Patents for A61P 33 - Antiparasitic agents (21,787)
09/2004
09/30/2004WO2003092583A3 Methods and compositions for treating ectoparasite infestation
09/30/2004US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating
09/30/2004US20040192752 Anti-HIV pyrazole derivatives
09/30/2004US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases
09/30/2004US20040191272 Methods and reagents for vaccination which generate a CD8 T cell immune response
09/30/2004US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy
09/30/2004US20040191234 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients
09/30/2004US20040191214 Nucleoside vaccine adjuvants
09/29/2004EP1461443A2 Carbohydrate-associated proteins
09/29/2004EP1461340A2 Trioxane derivatives as antimalaria or anticancer compounds
09/29/2004EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
09/29/2004EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
09/29/2004EP1461034A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
09/29/2004EP1461019A2 Bioadhesive drug delivery system with enhanced gastric retention
09/29/2004EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases
09/29/2004CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases
09/28/2004US6797718 Ether substituted imidazopyridines
09/28/2004US6797716 Imidazonaphthyridines
09/28/2004US6797701 Topical mixture; containing avermectin, milbemycin
09/23/2004WO2004080471A1 A new use for scorpion venom as product for malaria treatment and prophylaxis
09/23/2004WO2004080420A2 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
09/23/2004WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
09/23/2004US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors
09/23/2004US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues
09/23/2004US20040185050 Administering antimalarial agent to interfere with infection of hepatocytes by Plasmodium such as primaquine; preventing spread in vivo
09/23/2004DE10303254B3 3,3-Dimethyl-8-oxoisochinoline, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und deren Verwendung 3,3-dimethyl-8-oxoisochinoline, processes for their preparation, pharmaceutical compositions containing them and their use
09/22/2004EP1459766A1 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
09/22/2004EP1458746A2 Cyclic tetrapeptide compound and use thereof
09/22/2004EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
09/22/2004EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives
09/22/2004EP1458676A2 Compounds for the treatment of inflammatory disorders
09/22/2004EP1458401A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
09/22/2004EP1458249A1 Food supplement for animals
09/22/2004EP1373298B1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same
09/22/2004EP1235925A4 Feeding assay for identifying nematicidal compounds
09/22/2004EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
09/22/2004EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
09/22/2004CN1531543A Synthetic derivatives of 21-butenyl and related spinosyns
09/22/2004CN1531525A Organic compounds
09/22/2004CN1531426A Organic compounds
09/22/2004CN1530140A Vermis expelling resinate and its preparation
09/21/2004US6794545 Conformationally restricted polyamine analogs as disease therapies
09/21/2004US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease
09/21/2004US6794155 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen
09/16/2004WO2004078099A2 Compositions and methods for the generation of protective immune response against malaria
09/16/2004WO2004041167A3 Antiprotozoal ring-substituted phospholipids
09/16/2004WO2003096989A3 Anti tubercular drug: compositions and methods
09/16/2004WO2003095398A3 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
09/16/2004WO2003052048A3 Nucleic acid-associated proteins
09/16/2004WO2003045318A3 Manipulation of cytokine levels using cd83 gene products
09/16/2004US20040181047 33 human secreted proteins
09/16/2004US20040181037 Phosphatidyl serine receptors and uses thereof
09/16/2004US20040180842 antibiotics and antiprotozoa agents
09/16/2004US20040180034 Anthelmintic resinates and a method for their preparation
09/16/2004CA2545779A1 Compositions and methods for the generation of protective immune response against malaria
09/15/2004EP1457213A1 Anthelmintic resinates and a method for their preparation
09/15/2004EP1456171A1 Substituted cyclohexane derivatives
09/15/2004EP1456170A1 Aminoacetonitrile derivatives and their use for controlling parasites
09/15/2004EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
09/15/2004EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity
09/15/2004EP1455757A2 Methods for wet granulating azithromycin
09/15/2004EP1254135B1 Aminoheterocyclylamides as pesticides and antiparasitic agents
09/15/2004EP1001806B1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
09/15/2004CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells
09/15/2004CN1529552A Amenoacetonitrile compounds for controlling endoparasites
09/15/2004CN1528774A Improved method for preparing anti-parasite preparation
09/15/2004CN1528329A Ivermectin slow-release injecta, and preparing process and use method thereof
09/15/2004CN1528310A Combined slow-release agent for preventing and treating domstic aminal schistosome, fascioliasis, cestodiasis and nematodiasis and preparing method thereof
09/15/2004CN1528309A Complex artemisia apiacea extract
09/15/2004CN1528272A Agrimophol drop pill and preparing method thereof
09/15/2004CN1166639C Antimalarial quinolin derivatives, its preparation and use
09/14/2004US6790830 Use of 3-position cyclosporin derivatives for hair growth
09/14/2004US6790440 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
09/10/2004WO2004075921A1 Inclusion complex of artemisinin or derivates thereof with cyclodextrins
09/10/2004WO2004075912A1 Use of pgrp, lrrp and ctl proteins to trigger an anti-plasmodium immune response in anopheles species
09/10/2004WO2004075909A1 USE OF THIOESTER-CONTAINING PROTEINS (TEPs) FOR TRIGGERING/INDUCING AN IMMUNE RESPONSE IN MOSQUITOES OF ANOPHELES AGAINST PLASMODIUM
09/09/2004US20040176431 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use
09/09/2004US20040176326 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
09/09/2004US20040175803 Interferon-alpha induced gene
09/09/2004US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering
09/09/2004US20040175392 Compositions and methods for the generation of protective immune responses against malaria
09/09/2004US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine
09/09/2004US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human
09/08/2004EP1454905A1 Novel substance fki-1083 and process for producing the same
09/08/2004EP1454136A2 Methods and means for influencing intracellular communication and intracellular organelle transport
09/08/2004EP1453965A2 Dna vaccine
09/08/2004EP1453855A1 Antimicrobial bolisin peptides
09/08/2004EP1453837A2 Targeted therapeutics and uses thereof
09/08/2004EP1453829A1 Sulfonamido substituted imidazopyridines
09/08/2004EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
09/08/2004EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
09/08/2004EP1453508A1 Tempamine compositions and use against cellular oxidative damage
09/08/2004EP1453507A2 Solubilized topoisomerase poison agents
09/08/2004EP1453482A1 Radioopaque sustained release pharmaceutical system
09/08/2004EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/08/2004EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/08/2004EP1194416B1 Halopyrimidines
09/08/2004CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor
09/08/2004CN1526722A New taraxerol derivative and its prepn and use
09/08/2004CN1526406A Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease